PAN
Kailua, Hawaii, 96740, United States
NCT Number: NCT02260167
Treating with measures that may improve metabolic functioning of neurons in an integrated protocol
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Kailua, Hawaii, 96740, United States
Most organ failure results in modest drops in function until over 50% of function is lost. At a certain point, even modest drops in physiologic activity result in dramatic drops in clinical function. Though less homogeneous than in other organs, clinical experience and the literature suggests a similar process occurs in the brain. The hypothesis is that by using an integrated protocol to, essentially, "tune up" neuronal function, a 5-10 % improvement in metabolic functioning may translate to significant improvement in clinical functioning. This tune-up will include "MIND":
M- Metabolism-- optimizing hormonal function I- Infections-- looking for and eliminating N- Nutritional and herbal support D- Drugs- Weaning subjects off unneeded medications
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: MIND Protocol
Time frame: 6 months
Looking to see what percent of patients show improvement
Time frame: 6 months
Time frame: 6 months
Practitioners Alliance Network
Other
Effective Treatment of Alzheimer's and Dementia With the MIND Protocol
Acronym: MIND
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00149175
Alzheimer Disease, Alzheimer's Disease
Caen, France
View Trial DetailsNCT04426539
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04603482
Alzheimer Disease, Alzheimer's Disease
Cleveland, Ohio, United States
View Trial DetailsNCT04445831
Alzheimer Disease, Alzheimer's Disease
Helsinki, Finland
View Trial Details